Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/20/18 → 08/11/22 |
Funding
- Osiris Therapeutics Incorporated: $13,594.00
A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension Option to Evaluate the Safety and Efficacy of GrafixPL PRIME for the Treatment of Chronic Venous Leg Ulcers
- Kokkosis, Angela (CoPI)
- Tassiopoulos, Apostolos (CoPI)
- Gasparis, Antonios (PI)
- Loh, Shang (CoPI)
- Sikalas, Nicholas (CoPI)
Project: Research